Aegerion sales and marketing update

Aegerion provided pricing for its homozygous familial hypercholesterolemia (hoFH) drug Juxtapid lomitapide in a presentation at the 31st annual JPMorgan Healthcare Conference on Jan. 8. The company said the

Read the full 295 word article

How to gain access

Continue reading with a
two-week free trial.